Silicon Laboratories (SLAB) Expected to Announce Quarterly Earnings on Tuesday

Silicon Laboratories (NASDAQ:SLABGet Free Report) will likely be posting its Q3 2025 results before the market opens on Tuesday, November 4th. Analysts expect Silicon Laboratories to post earnings of $0.30 per share and revenue of $205.04 million for the quarter. Silicon Laboratories has set its Q3 2025 guidance at 0.200-0.400 EPS.Investors may visit the the company’s upcoming Q3 2025 earningresults page for the latest details on the call scheduled for Tuesday, November 4, 2025 at 8:30 AM ET.

Silicon Laboratories (NASDAQ:SLABGet Free Report) last announced its quarterly earnings data on Tuesday, August 5th. The semiconductor company reported $0.11 EPS for the quarter, topping analysts’ consensus estimates of $0.09 by $0.02. Silicon Laboratories had a negative return on equity of 7.21% and a negative net margin of 14.88%.The firm had revenue of $192.85 million during the quarter, compared to analyst estimates of $192.57 million. During the same period last year, the company earned ($0.56) earnings per share. The company’s revenue was up 32.6% on a year-over-year basis. On average, analysts expect Silicon Laboratories to post $-1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Silicon Laboratories Trading Up 0.0%

Silicon Laboratories stock opened at $135.15 on Tuesday. The company has a market cap of $4.43 billion, a PE ratio of -41.97 and a beta of 1.51. Silicon Laboratories has a 1 year low of $82.82 and a 1 year high of $160.00. The company’s 50-day moving average is $134.45 and its two-hundred day moving average is $129.56.

Insider Activity at Silicon Laboratories

In related news, SVP Brandon Tolany sold 1,800 shares of the firm’s stock in a transaction on Friday, August 29th. The stock was sold at an average price of $133.57, for a total transaction of $240,426.00. Following the sale, the senior vice president owned 62,328 shares of the company’s stock, valued at approximately $8,325,150.96. This trade represents a 2.81% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. In the last three months, insiders have sold 12,070 shares of company stock valued at $1,703,472. 1.60% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Silicon Laboratories

Several large investors have recently modified their holdings of SLAB. State Street Corp raised its position in shares of Silicon Laboratories by 0.5% during the second quarter. State Street Corp now owns 1,517,813 shares of the semiconductor company’s stock worth $223,665,000 after purchasing an additional 7,139 shares during the period. Bank of America Corp DE grew its position in shares of Silicon Laboratories by 1.7% in the 2nd quarter. Bank of America Corp DE now owns 458,791 shares of the semiconductor company’s stock valued at $67,607,000 after purchasing an additional 7,743 shares during the period. AQR Capital Management LLC increased its stake in Silicon Laboratories by 1,970.7% during the 2nd quarter. AQR Capital Management LLC now owns 370,492 shares of the semiconductor company’s stock worth $54,516,000 after purchasing an additional 352,600 shares in the last quarter. Squarepoint Ops LLC raised its holdings in Silicon Laboratories by 244.1% during the 2nd quarter. Squarepoint Ops LLC now owns 167,595 shares of the semiconductor company’s stock worth $24,697,000 after buying an additional 118,883 shares during the period. Finally, Alliancebernstein L.P. lifted its stake in Silicon Laboratories by 18.0% in the second quarter. Alliancebernstein L.P. now owns 142,206 shares of the semiconductor company’s stock valued at $20,955,000 after buying an additional 21,663 shares in the last quarter.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on SLAB shares. Susquehanna boosted their price target on shares of Silicon Laboratories from $110.00 to $150.00 and gave the stock a “neutral” rating in a research note on Tuesday, July 22nd. Weiss Ratings reiterated a “sell (d-)” rating on shares of Silicon Laboratories in a research report on Wednesday, October 8th. KeyCorp raised their price target on Silicon Laboratories from $160.00 to $180.00 and gave the stock an “overweight” rating in a research report on Tuesday, July 8th. Morgan Stanley decreased their price objective on Silicon Laboratories from $157.00 to $144.00 and set an “equal weight” rating for the company in a research note on Wednesday, August 6th. Finally, Barclays upped their price objective on Silicon Laboratories from $100.00 to $130.00 and gave the company an “equal weight” rating in a report on Tuesday, August 5th. Five analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, Silicon Laboratories presently has an average rating of “Hold” and a consensus target price of $151.13.

Read Our Latest Analysis on SLAB

About Silicon Laboratories

(Get Free Report)

Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.

Featured Articles

Earnings History for Silicon Laboratories (NASDAQ:SLAB)

Receive News & Ratings for Silicon Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silicon Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.